A B S T R A C T A detailed investigation of the purification of pyrrole-2-carboxylate (PCA) from human and rat urine indicates that previously reported mean values overestimate the correct quantity of free PCA by a factor of approximately three for rat urine and approximately five for human urine. Although several criteria of purity were satisfied by a previous method, pyrrolereactive impurities were still present in the final fractions. These impurities are separated from PCA by chromatography through an amino acid analyzer ionexchange resin. With the corrected method, normal human values for endogenous urinary PCA in 16 individuals averaged 0.51 gmol/day, with a range of 0.20-1.3 ,umol and a SD of 0.31 /Amol. The probable source of human PCA is free hydroxy-L-proline, as inferred from the high value for PCA in the urine of a subject with hereditary hydroxyprolinemia, and from the threeto eightfold elevation in PCA excretion by two normal subjects after a large oral load of hydroxy-L-proline. Subcutaneous administration of [2-"C]PCA to a single human subject indicated almost complete conversion of the exogenous compound to derivatives, which are largely excreted in the urine. Data are discussed suggesting that much or all of the PCA in human urine may be formed in urine from a labile precursor, presumably A1-pyrroline-4-hydroxy-2-carboxylate.
INTRODUCTION
Pyrrole-2-carboxylic acid was synthesized over a century ago (2) , but its history as a compound of biological origin is rather recent. It was first identified as a degradation product of sialic acids (3), then as a These studies comprise portions of a doctoral thesis (1) submitted to the University of Maryland by Anne M. Heacock. The thesis should be consulted for many details not presented in this paper.
Dr. Heacock's present address is Mental Health Research earlier methods for isolating and measuring urinary PCA, with the conclusion that all previously reported values considerably overestimate the quantity of free PCA excreted. We also report studies on the effect of elevated body levels of free hydroxy-L-proline on PCA excretion, on the excretion pattern after administering radioactive PCA to man, and on the source and site of PCA formation.
METHODS
Purification of PCA from human urine: method 1. Urine from healthy volunteers was collected in bottles containing 2 ml of toluene and 20 ml of 1 M Tris, pH 9.0. No attempt was made to control diet or activity in these subjects. The 24-h collection began after the first morning urine was discarded and included the first morning urine of the following day. Samples were stored at -15'C or analyzed within a day after collection. The volume was measured and a 50-ml sample was removed; to it was added [3H] -PCA (4-6 X 10' dpm). The urine sample was adjusted to pH 3-4 with 2 N HCl and extracted with 125 ml of ether in a continuous liquid-liquid extractor for at least 4 h (sometime overnight) at room temperature. The ether extract was brought almost to dryness in a flash evaporator at 350C, taken up in 4 ml of water, adjusted to pH 2-4 if necessary, and applied to a 1 X 10-cm column of Dowex-50 H+ (X8, 100-200 mesh, Dow Chemical USA, Membrane Systems Div., Midland, Mich.). The column was washed with distilled water and the first 50 ml of effluent were collected, evaporated to dryness, brought to 2 ml with water, and analyzed for PCA and radioactivity. By this method, PCA was stable in urine kept for 18 h at room temperature under collection conditions, as determined either by adding authentic PCA to a sample of urine or comparing measurements of endogenous PCA made immediately and after storage.
Further purification of PCA. The ether extract of urine was concentrated to 10-15 ml in a flash evaporator and extracted with 10 ml of 0.1 N NaOH by vigorous shaking in a screw-cap tube. The water phase was brought to 0.5 N in HCl, placed in a distilling flask, and heated over a flame almost to dryness; the distillate was collected and pyrrole-reactive material was measured with reference to a pyrrole standard, freshly distilled and appropriately diluted.
Chromatography and electrophoresis. The U of catalase, and 30 14g of FAD were added. After 22 h, the incubation was stopped by adding 1 ml of 2 N HCl, the volume was brought to 50 ml with water, the pH was adjusted to 3.5-4.0, and the solution was extracted with 125 ml of ether in a liquid-liquid extractor for 4 h. The ether layer was evaporated to dryness on a flash evaporator, brought to 4 ml with water, and applied to a 1.1 X 25-cm column of Dowex-50 H+. The column was eluted with water, collecting 1.5-ml fractions. Usually two peaks of radioactivity emerged from the column; the second, larger peak was PCA. After concentration in a flash evaporator, its identity and purity was checked by paper electrophoresis at pH 5.6 (see above); labeled material traveled with authentic PCA, detected by staining the paper with p-dimethylaminobenzaldehyde as described above. The tritiated PCA represented 10-15%o of the initial [G-3H]allohydroxy-D-proline and had a specific radioactivity 50%o that of the initial hydroxy-L-proline. In the enzymatic conversion of hydroxy-L-proline to allohydroxy-D-proline, the specific activity diminished by 35%o, a measure of the tritium in the a-position (15) . A further drop of 15% occurred on oxidation and/or dehydration to PCA.
[5-3H] PCA was prepared similarly from [5-3H] hydroxy-L-proline. The latter was converted to [5-3H] allohydroxy-Dproline essentially as described above. Oxidation of the Depimer (4-8 X 10' dpm), however, was carried out with the addition of 500 ,umol of unlabeled allohydroxy-D-proline and was catalyzed by crude bacterial allohydroxy-D-proline oxidase (5). The PCA formed was isolated as described above and represented 28% of the initial allohydroxy-Dproline. Unexpectedly, specific activity of the PCA was equal to that of the allohydroxy-D-proline and hydroxy-Lproline, indicating no loss of tritium from the 5-position of hydroxyproline. Tentatively, we attribute this to an isotope effect resisting the loss of tritium on tautomerization of the pyrrole ring.
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A. M. Heacock and E. Adams [2-14C] PCA was prepared from 50 AGCi of the mixed isomers of [2-`4C] hydroxy-DL-proline. In this case, the epimerization step was omitted and the oxidation step was carried out as described for the preparation of [G-3H]PCA. Radioactive PCA was stored in 0.001 M NaOH at -15'C. Some decomposition occurred over a period of several months, as inferred from the appearance of increasingly prominent peaks, which were not clearly retarded on the Durrum DC-1 column, but emerged at about 12 and 30 min.
Amino acid analysis. For the experiments described here, urinary y-hydroxyglutamate, free hydroxyproline, and other relevant amino acids were determined with the Technicon amino acid analyzer (Technicon Instruments Corp., Tarrytown, N. Y.), with a column (0.6 X 63 cm) of Durrum DC-1 resin. The elution system began with Durrum Pico Buffer A adjusted to pH 2.95, and followed after 45 min with the same buffer at pH 3.30. The column operation otherwise was as noted under method 2 for PCA. Approximately half the column output was pumped into the auto-analyzer/recorder portion of the analyzer, in the usual way, while the remaineder was collected in a fraction collector.
Mass spectra. Mass spectra of authentic PCA and of PCA purified from human urine by method 2 were obtained with a Dupont 490 mass spectrometer (E. I. Dupont de Nemours & Co., Wilmington, Del.), operating at a source temperature of 180' C; samples in aqueous solution were introduced via the batch inlet. The urine sample, corresponding to the middle peak of Fig. 2B , was passed through a small Dowex 50H+ column as in method 1; the slight retardation of PCA on Dowex 50Hi permitted essentially complete separation from the citrate buffer in the sample applied.
Alkalinization and NaBH4 treatment of urine. To maintain an alkaline urine during the collection of human urine, 4.2 g of NaHCO, was ingested at the beginning of each day's urine collection; 1.2 g of NaHCOs was taken every 2-3 h throughout the day. All urine samples, collected at 1-2 h intervals, were at pH 7-8. At each collection, urine samples were divided into equal portions and each was brought to 0.1 N in NaOH. To one sample, NaBH4 (4 mg/ml) was added; the other was not treated. Both samples were then acidified to pH 3.5 with 2 N HCl, and each was extracted with ether and analyzed for PCA by method 2.
Sources and purity of compounds. Allohydroxy-D-proline and hydroxy-L-proline were purchased from Sigma Chemical Co. Hydroxy-L-proline was recrystallized twice from water-ethanol. It was judged essentially free of PCA by adding radioactive PCA to an acidified solution of 30 mmol of hydroxyproline and extracting this solution with ether. The recovery of labeled PCA in the ether extract (40-50%) was associated with no detectable PCA by colorimetric assay; the sensitivity of this assay indicated that contamination of hydroxy-L-proline with PCA could not have exceeded 0.00006%. Hydroxy-L-proline was also found to contain less than 0.0005% of a D-isomer of hydroxyproline by tests with hog kidney D-amino acid oxidase, as described in detail elsewhere (1, 17) . Threo-,y-hydroxy-Lglutamate was purchased from Calbiochem (San Diego, 
RESULTS
PCA excretion by two methods. Initial data for the urinary excretion of PCA by man were obtained by method 1, which appeared valid by a number of criteria. First, the method had been tested with rat urine in the following ways: (a) Endogenous PCA in rat urine, to which radioactive PCA was added, was purified by method 1; a further purification step, paper electrophoresis, then failed to alter the specific radioactivity. (b) Urinary PCA, labeled from radioactive precursors (proline or hydroxyproline) administered to the rats, was purified by method 1; the labeled material failed to separate from authentic unlabeled PCA by paper electrophoresis or by thin-layer chromatography in three solvents. (c) ["C]PCA in rat urine, labeled from administered L-[U-`C]proline, was purified by method 1, diluted with unlabeled PCA, then reduced catalytically (10% Pd catalyst on charcoal, hydrogenation at 55 lb/in', room temperature, 44 h). Proline, formed in 20% yield, was separated from the residual PCA by retention on a Dowex-50 H' column and elution with 2 N HCl. It was then purified on the Durrum DC-1 column by elution with 0.066 M sodium citrate at pH 3.30 (amino acid analyzer conditions otherwise as under Methods). After a further purification step by paper electrophoresis (as noted for hydroxyproline, under Methods), the proline was eluted and found to have the same specific radioactivity as the PCA (purified by method 1) from which it had been derived.
In observations with endogenous PCA purified by method 1 from human urine, paper electrophoresis after addition of radioactive PCA similarity failed to alter the specific radioactivity. Like the PCA so purified from rat urine, the p-dimethylaminobenzaldehyde-reactive material purified by method 1 from human urine appeared to move with authentic PCA in several sol- vents on thin-layer chromatography. Finally, the determination of this material purified by method 1 was c-ompared with the pyrrole obtained by distillation of the ether extract; values by both methods were in good agreement. In addition, as has been noted, our values for the 24-h excretion of PCA in human urine, de- termined by method 1, were in agreement with those based on two variations of a distillation method (12, 13) .
Despite these numerous indications of purity of the PCA obtained by method 1, several later findings led us to question the validity of this method. On subjecting PCA so purified (and labeled by the addition of radioactive PCA) to further chromatography on Biogel P-2 columns (Bio-Rad Laboratories, Richmond, Calif.), the peak of chromogenic material (p-dimethylaminobenzaldehyde assay) was eluted slightly ahead of the peak of radioactivity; in contrast, chromatography with authentic PCA always showed coincidence of chromogenic material and radioactivity. Similar findings were made with cellulose chromatography (Whatman cellulose powder, eluted with tert-butyl alcohol: 1 N NH40H, 4: 1) or with silicic acid chromatography (eluted with toluene: ethanol, 7: 3), in that there was some separation of purified "PCA" and radioactive PCA. A possible isotope effect, attributable to the use of ['H]PCA as the radioactive marker, was not borne out when [2-_1C] PCA behaved in the same manner. Possible polymerization or other alteration of urinary PCA during the purification procedure was excluded as an explanation, by trials in which authentic PCA, added to the initial urine samples and carried through all the procedures of method 1, failed to separate from added radioactive PCA during the various forms of chromatography noted above.
Because of slight retardation of PCA on Dowex-50 H', the greater resolution of an amino acid analyzer cation exchange column was tested. This procedure succeeded in separating the "PCA" fraction of method 1 into three chromogenic peaks (Fig. 2) . Only one of these coincided with authentic PCA, either labeled or unlabeled, and whether added immediately before this column procedure or carried through all previous steps. The peak coinciding with authentic PCA was also consistent with PCA in that the spectrum of its chromogen with p-dimethylaminobenzaldehyde was identical with that from PCA. An additional identification of material in this peak was based on a comparison of its mass spectrum with that of authentic PCA. The latter compound, whose mass spectrum we were unable to find reported, gave peaks at the following m/e ratios (relative intensities in parentheses) : 28(100), 31(30), 32 (20) , 29 (19) , 44 (19) , 76 (16), 69(14), and 111(0).
Material from urine gave a spectrum consistent with that of the standard.
From the results of this added step, which constituted method 2, it appeared that method 1 had overestimated the daily excretion of PCA in the rat by a factor of 2-3, and the daily excretion of PCA in man by a factor of 5-6. Effect of an oral load of hydroxy-L-proline. The effect of an oral load of hydroxy-L-proline on PCA excretion by two subjects is summarized in Table II. Urine was collected for 24 h; hydroxyproline ingestion began shortly after the start of the urine collection and was divided into equal doses of 100 mg/kg of body weight, taken every 2 h for 12-15-h period. It is notable that both subjects experienced nausea and dizziness beginning approximately 12 h after the first dose of hydroxyproline and lasting for several hours. Scriver and Goldman (19) reported muscle aching, mild pyrexia, and nausea beginning about 12 h after infusing hydroxyproline in human subjects. As shown in Table II , free PCA in the urine excreted by both individuals during the period of hydroxyproline loading greatly exceeded their own control values and fell at the limit of or beyond the range of 16 control values (Table I) .
Level of PCA excretion in a hydroxyprolinemic subject. It was of interest to examine PCA excretion in an individual with impaired catabolism of hydroxy-Lproline via the major pathway, and consequent marked plasma elevation of free hydroxyproline. A 24-h urine was obtained' from a patient who has been the subject of several extensive studies (20) (21) (22) . Our determination of free hydroxy-L-proline in this sample (301 mg/24 h) agreed with previous measurements (22) . Two assays of the PCA content of this patient's urine by method 1 averaged 2.9 Amol, a value not significantly different from the mean of 22 values reported earlier by this method (10) or by the values reported in the present paper (Table I) . However, the more accurate value obtained by method 2 was 1.4 /Amol, a value approximately three times higher than the normal mean by this method.
Excretion of radioactivity after injection of [2-14C]-PCA. [2-"C]PCA was dissolved in sterile 0.9% saline and filtered through a sterile 0.45-Am Millipore filter (Millipore Corp., Bedford, Mass.). A sample of this solution, chromatographed on the Durrum DC-1 column as outlined for method 2, indicated that essentially all the radioactivity was eluted in the same position as authentic PCA; less than 1% was eluted in the 15-30-min fractions. The [2-'4C]PCA (7.8 /Ci, 0.42 Amol) was administered subcutaneously in two sites to a single subject (subject 2, Table I ). Urine was col- 2 We acknowledge with thanks the kindness of Dr. Vivian E. Shih, Massachusetts General Hospital, in sending us this sample. lected for two consecutive 24-h periods, the first period beginning at the time of PCA administration. The first 24-h urine contained 91% of the radioactivity injected; the second 24-h urine contained no detectable radioactivity. A 60-ml portion of the first 24-h urine, to which 1 Amol of unlabeled PCA had been added, was extracted with ether in the usual way; about 20% of the urine radioactivity was ether-extractable. The ether extract was dried, taken up in water, and passed through a Dowex-50 H' column (1 X 10 cm). The radioactive effluent was chromatographed through the Durrum DC-1 column as under method 2. Most of the radioactivity was eluted in a peak at 25 min. The free carrier PCA, which eluted at 85 min, contained only a trace of radioactivity. After these tubes were pooled and losses of radioactivity in PCA were corrected by the recovery of carrier PCA, only 0.33% of the total radioactivity in urine was present as free PCA.
Endogenous PCA in alkaline urine. Data presented elsewhere (1) suggested that much or all of the PCA found in the urine of rats given hydroxy-L-proline or allohydroxy-D-proline may be formed in the urine itself rather than in the tissues. The basis for this inference was that after administration to rats of radioactive PCA, urinary radioactivity was found largely in water-soluble form. In contrast, PCA in the urine after precursor administration was present largely as ether-extractable free PCA. These findings could be most easily explained if the presumptive intermediate between hydroxyproline and PCA, A1-pyrroline-4-hydroxy-2-carboxylate ( Fig. 1) , were readily excreted in the urine but were then rapidly converted to PCA at the usual acid pH of bladder or voided urine. The acid catalysis of the pyrroline compound to PCA was first reported by Radhakrishnan and Meister (4) . To examine this question for endogenous PCA in man, urine was collected from a single subject (subject 1, Table I ) during a period of ingestion of NaHCO3 sufficient of maintain an alkaline urine, as noted under Methods. Half of each urine sample was treated with NaBH4 to reduce any A'-pyrroline-4-hydroxy-2-carboxylate to hydroxyproline (23) . The value for PCA in a control sample of urine was 0.46 Amol/24 h; the value for an NaBH4-treated sample was 0.34 uLmol/24 h, or about 25% less.
DISCUSSION
The data presented correct previously reported (10, 12, 13) estimates of the 24-h urinary excretion of PCA in man. Similar studies in the rat (1) , to be presented elsewhere, also revise earlier data for the level of endogenous PCA in rat urine. The revised values for man indicate a range of only 0.2-1.3 4mol/day for the group studied, with a mean value of 0.5 Iumol. Earlier values with a mean five times that of the present corrected values were in agreement with data obtained by different methods in two other laboratories. It is worth emphasizing the difficulties in reliably measuring these low levels of PCA in urine, especially in the presence of other compounds similar in extraction behavior and in the capacity to react with p-dimethylaminobenzaldehyde. Presumably these interfering compounds may also be pyrrole derivatives. The evidence presented suggests that earlier methods were measuring compounds other than free PCA, but similar enough to migrate with it on paper electrophoresis and on several chromatographic solvents, and to be degraded similarly to volatile compounds which could be distilled with the pyrrole derived from PCA. The interfering components, however, were separable from PCA by refined ion-exchange chromatography.
A natural consideration is that the interfering compounds separable only by method 2 are actually degradation or polymerization products of PCA, formed either metabolically or under the separation conditions. Against this possibility, however, was the finding that on chromatographing free PCA from rat urine, which had been labeled by the administration of labeled allohydroxy-D-proline, only the true PCA peak, and not the early or late peaks (Fig. 2) , was labeled. In addition, as can be seen by comparing endogenous PCA values by methods 1 and 2 (subjects 1 and 2, Table I) with corresponding values after a large hydroxy-L-proline load (Table II) , there was no significant increase in these other pyrrole-reactive compounds, which are estimated by the difference between PCA by method 1 and PCA by method 2. A similar but more striking conclusion comes from experiments with rats (1): large hydroxy-L-proline loads, which elevated true PCA over 30 times the control levels, failed to increase peaks 1 and 3 ( Fig. 2A) .
Radioactive PCA, added to urine and processed through the final column separation, also yielded only a single radioactive peak in the "true" PCA position. These findings would seem to exclude either the metabolic or chemical derivation from PCA of the interfering components separated by the final step of ionexchange chromatography.
The metabolic derivation of PCA in rat urine from hydroxy-L-proline is based on its marked increase by a hydroxy-L-proline load, its labeling from labeled hydroxy-L-proline, and the finding of an enzymatic basis for the oxidation of hydroxy-L-proline to A' pyrroline-4-hydroxy-2-carboxylate by rat kidney Lamino acid oxidase (1, 10, 11) . A similar inference can be drawn from the human data presented here. While the daily excretion of PCA on a body-weight basis is some 15-fold less in man (approximately 0.008 Amol/ kg) than in young rats (0.12 Amol/kg (1) ), the daily release from collagen of free hydroxyproline may also show a similar relationship, as calculated from the data of Weiss and Klein for the rat (24) and from Efron, Bixby, and Pryles for man (21) . Urinary PCA measurements from a hydroxyprolinemic subject gave a value three times the average value for our control series. Ingestion of a hydroxyproline load by two normal subjects should have elevated plasma levels of hydroxyproline to the range of the hydroxyprolinemic subject (0.2-0.5 mM) for much of the period of urine collection, by analogy with the findings of Efron et al. (21) for the effect of a single oral hydroxyproline load. In agreement with this inference and the possible relationship to PCA formation, the two subjects showed respective elevations of excreted PCA four and eight times their own control values.
Present evidence indicates that in the rat exogenously administered PCA is largely converted to water-soluble conjugates. In the first such report (25) , after intraperitoneal injection in rats of 10 mg of [1-'4C]PCA, 23-37% of the radioactivity was excreted as free PCA, the remaining urinary radioactivity being largely present in water-soluble conjugates. In comparable experiments of ours (1) with significantly smaller doses of labeled or unlabeled PCA, only about 5% of the administered compound was recovered as free PCA. In the single human experiment reported here, less than 1% of administered radioactive PCA was recovered as free PCA. In aggregate, data for both rat and man indicate that exogenous PCA is essentially all excreted in the urine, most of it in conjugated form. From our single human case, it is not clear if the extremely efficient conjugation observed is a species characteristic or is characteristic of the small dose given.
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